Literature DB >> 27498672

Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.

Yingfei Li1, Yuqiang Nie1, Sanfang Tu2, Hong Wang1, Yongjian Zhou1, Yanlei Du1, Jie Cao3, Min Ye1.   

Abstract

Aberrant methylation of miRNAs is commonly observed in cancers. In the present study, we investigated the regulation of the miR-200 family and its role in regulating DNA methylation events in gastric cancer (GC). We demonstrated that miR‑200c was aberrantly expressed in GC and associated with histologic type and tumor progression. Hypermethylation of the promoter region was found to be responsible for the loss of miR-200c in GC cells. Demethylation agents led to recovery of miR-200c expression in GC cell lines. Moreover, DNMT3a knockdown abolished the hypermethylation of the miR-200c gene and induced upregulation of miR-200c expression, whereas ectopic DNMT3a expression increased miR-200c promoter methylation and decreased miR-200c expression. Conversely, transfection of miR-200c led to downregulation of DNMT3a protein and induced endogenous pre-miR-200c and pri-miR‑200c re-expression. Luciferase assays confirmed miR‑200c binding to the DNMT3a 3'UTR. Finally, ectopic expression of miR-200c or knockdown of DNMT3a expression impeded GC cell growth, migration and invasion. Taken together, these observations demonstrates a novel epigenetic feedback loop between miR-200c and DNMT3a in the carcinogenesis and progression of GC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27498672     DOI: 10.3892/or.2016.4996

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  LINC01303 promotes the proliferation and migration of laryngeal carcinoma by regulating miR-200c/TIMP2 axis.

Authors:  Dong Xiao; Xiangyan Cui; Ning Fang; Shujian Yu; Xin Wang
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Clinical Correlation of miR-200c/141 Cluster DNA Methylation and miR-141 Expression with the Clinicopathological Features of Colorectal Primary Lesions/Tumors.

Authors:  Zahra Taheri; Hamid Asadzadeh Aghdaei; Shiva Irani; Mohammad Hossein Modarressi; Zahra Noormohammadi
Journal:  Rep Biochem Mol Biol       Date:  2019-10

3.  MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.

Authors:  Yamei Pang; Jian Liu; Xiang Li; Guodong Xiao; Huangzhen Wang; Ganghua Yang; Yanbo Li; Shou-Ching Tang; Sida Qin; Ning Du; Henggang Zhang; Dapeng Liu; Xin Sun; Hong Ren
Journal:  J Cell Mol Med       Date:  2018-10-16       Impact factor: 5.310

4.  Methylation analysis of MIR200 family in Mexican patients with colorectal cancer.

Authors:  Carlos Rogelio Alvizo-Rodriguez; Maria de la Luz Ayala-Madrigal; Jesus Arturo Hernandez-Sandoval; Helen Haydee Fernanda Ramirez-Plascencia; Christian Octavio Gonzalez-Villaseñor; Nelly Margarita Macias-Gomez; Jorge Peregrina-Sandoval; Jose Miguel Moreno-Ortiz; Jesus A Valenzuela-Perez; Jose Alfonso Cruz-Ramos; Melva Gutierrez-Angulo
Journal:  J Investig Med       Date:  2019-12-23       Impact factor: 2.895

Review 5.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

Review 6.  Molecular therapies delaying cardiovascular aging: disease- or health-oriented approaches.

Authors:  Alessandra Magenta; Reggio Lorde; Sunayana Begum Syed; Maurizio C Capogrossi; Annibale Puca; Paolo Madeddu
Journal:  Vasc Biol       Date:  2020-01-16

7.  The mir-200 family regulates key pathogenic events in ascending aortas of individuals with bicuspid aortic valves.

Authors:  S Maleki; K A Cottrill; F-A Poujade; A Bhattachariya; O Bergman; J R Gådin; N Simon; K Lundströmer; A Franco-Cereceda; H M Björck; S Y Chan; P Eriksson
Journal:  J Intern Med       Date:  2018-10-02       Impact factor: 8.989

8.  DNMT3a promotes proliferation by activating the STAT3 signaling pathway and depressing apoptosis in pancreatic cancer.

Authors:  Wei Jing; Na Song; Yun-Peng Liu; Xiu-Juan Qu; Ya-Fei Qi; Ce Li; Ke-Zuo Hou; Xiao-Fang Che; Xiang-Hong Yang
Journal:  Cancer Manag Res       Date:  2019-07-10       Impact factor: 3.989

9.  miR-30a-3p inhibits the proliferation of liver cancer cells by targeting DNMT3a through the PI3K/AKT signaling pathway.

Authors:  Qiong Chen; Yuan Gao; Qin Yu; Feng Tang; Pei-Wei Zhao; Su-Kun Luo; Ju-Sheng Lin; Hong Mei
Journal:  Oncol Lett       Date:  2019-12-03       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.